DOCSLIB.ORG

Poisons List (Jersey) Order 1986

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Poisons List (Jersey) Order 1986 POISONS LIST (JERSEY) ORDER 1986 Revised Edition 20.775.60 Showing the law as at 1 January 2011 This is a revised edition of the law Poisons List (Jersey) Order 1986 Arrangement POISONS LIST (JERSEY) ORDER 1986 Arrangement Article 1 Poisons List ..................................................................................................... 5 2 Citation ............................................................................................................ 5 SCHEDULE 6 THE POISONS LIST 6 PART 1 6 PART 2 50 PART 3 52 Supporting Documents ENDNOTES 53 Table of Legislation History......................................................................................... 53 Table of Renumbered Provisions ................................................................................. 53 Table of Endnote References ....................................................................................... 53 Revised Edition – 1 January 2011 Page - 3 20.775.60 Poisons List (Jersey) Order 1986 Article 1 POISONS LIST (JERSEY) ORDER 19861 THE HEALTH AND SOCIAL SERVICES COMMITTEE in pursuance of Article 8 of the Pharmacy and Poisons (Jersey) Law 1952,2 orders as follows – Commencement [see endnotes] 1 Poisons List The list of substances which are to be treated as poisons for the purposes of the Poisons (Jersey) Law 1952,3 shall be as set out in the Schedule to this Order.4 2 Citation This Order may be cited as the Poisons List (Jersey) Order 1986. Revised Edition – 1 January 2011 Page - 5 20.775.60 SCHEDULE Poisons List (Jersey) Order 1986 SCHEDULE (Article 1) THE POISONS LIST PART 1 (Poisons which, subject to the provisions of the Pharmacy and Poisons (Jersey) Law 1952, are not to be sold except by a person who is an authorized seller of poisons.) Acebutolol Hydrochloride Acemetacin Acetanilide; alkyl acetanilides Acetarsol Acetazolamide Sodium Acetazolamide Acetohexamide Acetorphine; its salts; its esters and ethers; their salts Acetylcarbromal Acetylcholine Chloride Acetylcysteine Acetyldigitoxin Acetyldihydrocodeine; its salts Acetylstrophanthidin Acipimox Acitretin Aclarubicin Hydrochloride Aconite Root Aconite Acrosoxacin Actinomycin C Actinomycin D Acyclovir Adenosine Adicillin Adiphenine Hydrochloride Page - 6 Revised Edition – 1 January 2011 20.775.60 Poisons List (Jersey) Order 1986 SCHEDULE Adrenocortical Extract Aklomide Albendazole Alclofenac Alcuronium Chloride Aldesleukin Aldosterone Alfacalcidol Alfentanil Alfuzosin Hydrochloride Alkali flourides other than those specified in Part 2 of this List Alkaloids, the following; their quaternary compounds; any salt, simple or complex, of any substance falling within the following – Aconite, alkaloids of Atropine Belladonna, alkaloids of Brucine Calabar bean, alkaloids of Coca, alkaloids of Cocaine Codeine; its esters and ethers Colchicum, alkaloids of Coniine Cotarnine Curare, alkaloids of; curare bases Ecgonine; its esters and ethers Emetine Ephedra, alkaloids of Ergot, alkaloids of, whether hydrogenated or not; their homologues Gelsemium, alkaloids of Homatropine Hyoscine Hyoscyamine Jaborandi, alkaloids of Lobelia, alkaloids of Morphine, its esters and ethers Papaverine Pomegranate, alkaloids of Revised Edition – 1 January 2011 Page - 7 20.775.60 SCHEDULE Poisons List (Jersey) Order 1986 Quebracho, alkaloids of, other than the alkaloids of red quebracho Rauwolfia; alkaloids of; their derivatives Sabadilla, alkaloids of Solanaceous alkaloids not otherwise included in this List Stavesacre, alkaloids of Strychnine Thebaine Veratrum, alkaloids of Yohimba, alkaloids of Allergen Extracts Allopurinol Allylisopropylacetylurea Allylprodine; its salts Alphadolone Acetate Alphameprodine; its salts Alphaprodine; its salts Alphaxalone Alprazolam Alprenolol Alprenolol Hydrochloride Alprostadil Alseroxylon Alteplase Altizide Aluminium phosphide Alverine Citrate Amantadine Hydrochloride Ambenonium Chloride Ambuside Ambutonium Bromide Amcinonide Ametazole Hydrochloride Amethocaine Amidopyrine; its salts; amidopyrine sulphonates; their salts Amikacin Sulphate Amiloride Hydrochloride Page - 8 Revised Edition – 1 January 2011 20.775.60 Poisons List (Jersey) Order 1986 SCHEDULE Amino-alcohols esterified with benzoic acid, phenylaceticacid, phenylpropionic acid, cinnamic acid or the derivatives of these acids; their salts p-Aminobenzenesulphonamide; its salts; derivatives of p- aminobenzenesulphonamide having any of the hydrogen atoms of the p- amino group or of the sulphonamide group substituted by anotherradical; their salts p-Aminobenzoic acid, esters of; their salts Aminocaproic Acid Aminoglutethimide Aminopterin Sodium Aminorex; its salts Aminosalicylic Acid Amiodarone Hydrochloride Amiphenazole Hydrochloride Amitriptyline; its salts Amlodipine Besylate Ammonium Bromide Amodiaquine Hydrochloride Amorolfine Hydrochloride Amoxapine Amoxycillin Amoxycillin Trihydrate Amphomycin Amphomycin Calcium Amphotericin Ampicillin Ampicillin Sodium Ampicillin Trihydrate Amsacrine Amygdalin Amyl nitrite Amylocaine Hydrochloride Ancrod Androgenic, oestrogenic and progestational substances the following – Benzoestrol Derivatives of stilbene, dibenzyl or naphthalene with oestrogenic activity; their esters Revised Edition – 1 January 2011 Page - 9 20.775.60 SCHEDULE Poisons List (Jersey) Order 1986 Steroid compounds with androgenic or oestrogenic or progestational activity; their esters Angiotensin Amide Anileridine; its salts Anistreplase Anterior Pituitary Extract Anti-histamine substances, the following; their salts; their molecular compounds – Acrivastine Antazoline Astemizole Azatadine Maleate Azelastine Hydrochloride Bromodiphenhydramine Buclizine Carbinoxamine Cetirizine Dihydrochloride Chlorcyclizine Chlorpheniramine Cinnarizine Clemastine Clemizole Cyclizine Cyproheptadine 3-Di-n-butylaminomethyl-4,5,6-trihydroxyphthalide Dimethindene Maleate Diphenhydramine Diphenylpyraline Doxylamine Isothipendyl Loratidine Mebhydrolin Meclozine Phenindamine Pheniramine Phenyltoloxamine Promethazine Pyrrobutamine Terfenadine Thenalidine Page - 10 Revised Edition – 1 January 2011 20.775.60 Poisons List (Jersey) Order 1986 SCHEDULE Tolpropamine Triprolidine Substances being tetra-N-substituted derivatives of ethylenediamine or propylenediamine Antimony, chlorides of; oxides of antimony; sulphides of antimony; antimonates; antimonites; organic compounds of antimony Apiol Apomorphine; its salts Apramycin Apramycin Sulphate Aprotinin Arecoline Arecoline-Acetarsol Arecoline Hydrobromide Arprinocid Arsanilic Acid Arsenic Arsenical substances, the following, except those specified in Part 2 of this List; halides of arsenic; oxides of arsenic; arsenates; arsenites; organic compounds of arsenic Atenolol Atracurium Besylate Auranofin Azacyclonal; its salts Azaperone Azapropazone Azathioprine Azathioprine Sodium Azidocillin Potassium Azithromycin Dihydrate Azlocillin Sodium Aztreonam Bacampicillin Hydrochloride Bacitracin Bacitracin Methylene Disalicylate Bacitracin Zinc Revised Edition – 1 January 2011 Page - 11 20.775.60 SCHEDULE Poisons List (Jersey) Order 1986 Baclofen Bambermycin Bambuterol Hydrochloride Barbituric acid; its salts; derivatives of barbituric acid; their salts; compounds of barbituric acid; its salts; its derivatives, their salts, with any other substance Barium Carbonate Barium, salts of, other than barium sulphate and the salts of barium specified in Part 2 of this List Beclamide Beclomethasone Beclomethasone Diproprionate Belladonna Herb Belladonna Root Bemegride Bemegride Sodium Benactyzine; its salts Benapryzine Benethamine Penicillin Benorylate Benoxaprofen Benperidol Benserazide Benzathine Penicillin Benzbromarone Benzethidine; its salts Benzhexol; its salts Benzilonium Bromide Benzoctamine; its salts Benzoylmorphine; its salts Benzoyl Peroxide Benzquinamide Benzquinamide Hydrochloride Benztropine and its homologues; their salts Benzydamine Benzylmorphine; its salts Benzylpenicillin Page - 12 Revised Edition – 1 January 2011 20.775.60 Poisons List (Jersey) Order 1986 SCHEDULE Benzylpenicillin Calcium Benzylpenicillin Potassium Benzylpenicillin Sodium Betahistine dihydrochloride Betameprodine; its salts Betamethasone Betamethasone Adamantoate Betamethasone Benzoate Betamethasone Sodium Phosphate Betamethasone Valerate Betaprodine; its salts Betaxolol Hydrochloride Bethanechol Chloride Bethanidine Sulphate Bezafibrate Biperiden Hydrochloride Biperiden Lactate Bisoprolol Fumarate Bleomycin Bleomycin Sulphate Boldenone Undecylenate Bretylium Tosylate Bromhexine Hydrochloride Bromocriptine Mesylate Bromomethane Bromvaletone Brotizolam Budesonide Bufexamac Bumetanide Buphenine Hydrochloride Bupivacaine Bupivacaine Hydrochloride Buprenorphine Buprenorphine Hydrochloride Revised Edition – 1 January 2011 Page - 13 20.775.60 SCHEDULE Poisons List (Jersey) Order 1986 Buserilin Acetate Buspirone Hydrochloride Busulphan; its salts Butanilicaine Phosphate Butriptyline Hydrochloride Butylchloral Hydrate Calcipotriol Calcitonin Calcitriol Calcium Aminosalicylate Calcium Amphomycin Calcium Benzamidosalicylate Calcium Bromide Calcium Bromidolactobionate Calcium Carbimide Calcium Folinate Calcium Metrizoate Candicidin Cannabinol and its tetrahydro derivatives, prepared wholly or partly by synthesis; their 3-alkyl homologues; any esters or ether of any substance falling within this item Cannabis (the dried flowering or fruiting tops of Cannabis Sativa Linn); the resin of cannabis; extracts of cannabis; tinctures of cannabis; cannabin tannate Canrenoic Acid Cantharidin; cantharidates Capreomycin Sulphate Captodiame;
Load more

Recommended publications
  • NCAA [R] Drug-Testing Program, 1999-2000
    DOCUMENT RESUME ED 436 990 HE 032 608 AUTHOR Halpin, Ty, Ed. TITLE NCAA[R] Drug-Testing Program, 1999-2000. INSTITUTION National Collegiate Athletic Association, Indianapolis, IN. PUB DATE 1999-00-00 NOTE 15p. AVAILABLE FROM National Collegiate Athletic Association, P.O. Box 6222, Indianapolis, IN 46206-6222. Tel: 317-917-6222. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE MF01/PC01 Plus Postage. DESCRIPTORS Athletes; *College Athletics; Drug Abuse; *Drug Use Testing; Higher Education; Illegal Drug Use IDENTIFIERS *National Collegiate Athletic Association ABSTRACT The drug testing program supports NCAA's goal to protect the health and safety of student-athletes competing for their institutions, while reaffirming the organization's commitment to fair and equitable competition. Proposal Nos. 30 and 52-54 provide a program for the NCAA's members to ensure that no one athlete has a chemically-induced advantage or is pressured to use chemical substances. The program involves urine collection on specific occasions and laboratory analyses for substances on a list of banned drugs including stimulants, anabolic agents such as steroids, diuretics, illegal drugs, or peptide hormones. Consent forms must be signed by student athletes if they wish to participate in NCAA programs. (JM) Reproductions supplied by EDRS are the best that can be made from the original document. 6' 3r; - RUG- ESTING ROGRAI4 1999-2000 , Pso (2 BEST COPY AVAILABLE U.S. DEPARTMENT OF EDUCATION Office of Educational Research and Improvement PERMISSION TO REPRODUCE AND EDUCATIONAL RESOURCES INFORMATION DISSEMINATE THIS MATERIAL HAS CENTER (ERIC) BEEN GRANTED BY his document has been reproduced as received from the person or organization originating it.
    [Show full text]
  • The Detection and Determination of Esters
    Louisiana State University LSU Digital Commons LSU Historical Dissertations and Theses Graduate School 1958 The etD ection and Determination of Esters. Mohd. Mohsin Qureshi Louisiana State University and Agricultural & Mechanical College Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses Recommended Citation Qureshi, Mohd. Mohsin, "The eD tection and Determination of Esters." (1958). LSU Historical Dissertations and Theses. 501. https://digitalcommons.lsu.edu/gradschool_disstheses/501 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact [email protected]. Copright by Mohcl Mohsin Qureshi 1959 THE DETECTION AND DETERMINATION OF ESTERS A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Chemistry by Mohd. Mohsin Qureshi M.Sc., Aligarh University, 1944 August, 1958 ACKNOWLEDGMENT The author wishes to express his sincere apprecia­ tion and gratitude to Dr. Philip W. West under whose guidance this research was carried out. He is grateful to Dr. James G. Traynham for sup­ plying him with a number of esters and for his many helpful suggestions. The financial support given to him by the Continental Oil Company is gratefully acknowledged. He offers his sincere thanks to Miss Magdalena Usategul for her valuable suggestions and her ungrudging help during the course of this investigation. Dr. Anil K.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Muscarinic Acetylcholine Receptor
    mAChR Muscarinic acetylcholine receptor mAChRs (muscarinic acetylcholine receptors) are acetylcholine receptors that form G protein-receptor complexes in the cell membranes of certainneurons and other cells. They play several roles, including acting as the main end-receptor stimulated by acetylcholine released from postganglionic fibersin the parasympathetic nervous system. mAChRs are named as such because they are more sensitive to muscarine than to nicotine. Their counterparts are nicotinic acetylcholine receptors (nAChRs), receptor ion channels that are also important in the autonomic nervous system. Many drugs and other substances (for example pilocarpineand scopolamine) manipulate these two distinct receptors by acting as selective agonists or antagonists. Acetylcholine (ACh) is a neurotransmitter found extensively in the brain and the autonomic ganglia. www.MedChemExpress.com 1 mAChR Inhibitors & Modulators (+)-Cevimeline hydrochloride hemihydrate (-)-Cevimeline hydrochloride hemihydrate Cat. No.: HY-76772A Cat. No.: HY-76772B Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic Bioactivity: Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other… gastrointestinal, urinary, and reproductive systems and other… Purity: >98% Purity: >98% Clinical Data: No Development Reported Clinical Data: No Development Reported Size: 10mM x 1mL in DMSO, Size: 10mM x 1mL in DMSO, 1 mg, 5 mg 1 mg, 5 mg AC260584 Aclidinium Bromide Cat. No.: HY-100336 (LAS 34273; LAS-W 330) Cat.
    [Show full text]
  • Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
    processes Review Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development Outi M. H. Salo-Ahen 1,2,* , Ida Alanko 1,2, Rajendra Bhadane 1,2 , Alexandre M. J. J. Bonvin 3,* , Rodrigo Vargas Honorato 3, Shakhawath Hossain 4 , André H. Juffer 5 , Aleksei Kabedev 4, Maija Lahtela-Kakkonen 6, Anders Støttrup Larsen 7, Eveline Lescrinier 8 , Parthiban Marimuthu 1,2 , Muhammad Usman Mirza 8 , Ghulam Mustafa 9, Ariane Nunes-Alves 10,11,* , Tatu Pantsar 6,12, Atefeh Saadabadi 1,2 , Kalaimathy Singaravelu 13 and Michiel Vanmeert 8 1 Pharmaceutical Sciences Laboratory (Pharmacy), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland; ida.alanko@abo.fi (I.A.); rajendra.bhadane@abo.fi (R.B.); parthiban.marimuthu@abo.fi (P.M.); atefeh.saadabadi@abo.fi (A.S.) 2 Structural Bioinformatics Laboratory (Biochemistry), Åbo Akademi University, Tykistökatu 6 A, Biocity, FI-20520 Turku, Finland 3 Faculty of Science-Chemistry, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands; [email protected] 4 Swedish Drug Delivery Forum (SDDF), Department of Pharmacy, Uppsala Biomedical Center, Uppsala University, 751 23 Uppsala, Sweden; [email protected] (S.H.); [email protected] (A.K.) 5 Biocenter Oulu & Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7 A, FI-90014 Oulu, Finland; andre.juffer@oulu.fi 6 School of Pharmacy, University of Eastern Finland, FI-70210 Kuopio, Finland; maija.lahtela-kakkonen@uef.fi (M.L.-K.); tatu.pantsar@uef.fi
    [Show full text]
  • Properties and Units in Clinical Pharmacology and Toxicology
    Pure Appl. Chem., Vol. 72, No. 3, pp. 479–552, 2000. © 2000 IUPAC INTERNATIONAL FEDERATION OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE SCIENTIFIC DIVISION COMMITTEE ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)# and INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY CHEMISTRY AND HUMAN HEALTH DIVISION CLINICAL CHEMISTRY SECTION COMMISSION ON NOMENCLATURE, PROPERTIES, AND UNITS (C-NPU)§ PROPERTIES AND UNITS IN THE CLINICAL LABORATORY SCIENCES PART XII. PROPERTIES AND UNITS IN CLINICAL PHARMACOLOGY AND TOXICOLOGY (Technical Report) (IFCC–IUPAC 1999) Prepared for publication by HENRIK OLESEN1, DAVID COWAN2, RAFAEL DE LA TORRE3 , IVAN BRUUNSHUUS1, MORTEN ROHDE1, and DESMOND KENNY4 1Office of Laboratory Informatics, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark; 2Drug Control Centre, London University, King’s College, London, UK; 3IMIM, Dr. Aiguader 80, Barcelona, Spain; 4Dept. of Clinical Biochemistry, Our Lady’s Hospital for Sick Children, Crumlin, Dublin 12, Ireland #§The combined Memberships of the Committee and the Commission (C-NPU) during the preparation of this report (1994–1996) were as follows: Chairman: H. Olesen (Denmark, 1989–1995); D. Kenny (Ireland, 1996); Members: X. Fuentes-Arderiu (Spain, 1991–1997); J. G. Hill (Canada, 1987–1997); D. Kenny (Ireland, 1994–1997); H. Olesen (Denmark, 1985–1995); P. L. Storring (UK, 1989–1995); P. Soares de Araujo (Brazil, 1994–1997); R. Dybkær (Denmark, 1996–1997); C. McDonald (USA, 1996–1997). Please forward comments to: H. Olesen, Office of Laboratory Informatics 76-6-1, Copenhagen University Hospital (Rigshospitalet), 9 Blegdamsvej, DK-2100 Copenhagen, Denmark. E-mail: [email protected] Republication or reproduction of this report or its storage and/or dissemination by electronic means is permitted without the need for formal IUPAC permission on condition that an acknowledgment, with full reference to the source, along with use of the copyright symbol ©, the name IUPAC, and the year of publication, are prominently visible.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • NINDS Custom Collection II
    ACACETIN ACEBUTOLOL HYDROCHLORIDE ACECLIDINE HYDROCHLORIDE ACEMETACIN ACETAMINOPHEN ACETAMINOSALOL ACETANILIDE ACETARSOL ACETAZOLAMIDE ACETOHYDROXAMIC ACID ACETRIAZOIC ACID ACETYL TYROSINE ETHYL ESTER ACETYLCARNITINE ACETYLCHOLINE ACETYLCYSTEINE ACETYLGLUCOSAMINE ACETYLGLUTAMIC ACID ACETYL-L-LEUCINE ACETYLPHENYLALANINE ACETYLSEROTONIN ACETYLTRYPTOPHAN ACEXAMIC ACID ACIVICIN ACLACINOMYCIN A1 ACONITINE ACRIFLAVINIUM HYDROCHLORIDE ACRISORCIN ACTINONIN ACYCLOVIR ADENOSINE PHOSPHATE ADENOSINE ADRENALINE BITARTRATE AESCULIN AJMALINE AKLAVINE HYDROCHLORIDE ALANYL-dl-LEUCINE ALANYL-dl-PHENYLALANINE ALAPROCLATE ALBENDAZOLE ALBUTEROL ALEXIDINE HYDROCHLORIDE ALLANTOIN ALLOPURINOL ALMOTRIPTAN ALOIN ALPRENOLOL ALTRETAMINE ALVERINE CITRATE AMANTADINE HYDROCHLORIDE AMBROXOL HYDROCHLORIDE AMCINONIDE AMIKACIN SULFATE AMILORIDE HYDROCHLORIDE 3-AMINOBENZAMIDE gamma-AMINOBUTYRIC ACID AMINOCAPROIC ACID N- (2-AMINOETHYL)-4-CHLOROBENZAMIDE (RO-16-6491) AMINOGLUTETHIMIDE AMINOHIPPURIC ACID AMINOHYDROXYBUTYRIC ACID AMINOLEVULINIC ACID HYDROCHLORIDE AMINOPHENAZONE 3-AMINOPROPANESULPHONIC ACID AMINOPYRIDINE 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE AMINOTHIAZOLE AMIODARONE HYDROCHLORIDE AMIPRILOSE AMITRIPTYLINE HYDROCHLORIDE AMLODIPINE BESYLATE AMODIAQUINE DIHYDROCHLORIDE AMOXEPINE AMOXICILLIN AMPICILLIN SODIUM AMPROLIUM AMRINONE AMYGDALIN ANABASAMINE HYDROCHLORIDE ANABASINE HYDROCHLORIDE ANCITABINE HYDROCHLORIDE ANDROSTERONE SODIUM SULFATE ANIRACETAM ANISINDIONE ANISODAMINE ANISOMYCIN ANTAZOLINE PHOSPHATE ANTHRALIN ANTIMYCIN A (A1 shown) ANTIPYRINE APHYLLIC
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Poisons Act.Fm
    LAWS OF BRUNEI CHAPTER 114 POISONS Enactment No. 13 of 1956 Amended by S 103/1958 Enactment No. 6 of 1967 S 101/1979 1984 Edition, Chapter 114 Amended by S 16/1996 S 28/2001 GN 273/2002 REVISED EDITION 2015 B.L.R.O. 1/2015 LAWS OF BRUNEI Poisons CAP. 114 1 LAWS OF BRUNEI REVISED EDITION 2015 CHAPTER 114 POISONS ARRANGEMENT OF SECTIONS Section 1. Citation. 2. Interpretation. 3. Description of poisons. 4. Licensing Officers. 5. General prohibition with respect to importation and sale of poisons. 6. Prohibitions and provisions relating to sale of poisons. 7. Exemptions in respect of medicines. 8. Exemptions in respect of sale. 9. Possession of poisons. 10. Issue of licences. 11. Different kinds of licence. 12. Licences to be numbered and registered. 13. Annual list to be published. 14. Forms of licence. 15. Search and search warrants. 16. Powers of exemption. 17. Penalties. B.L.R.O. 1/2015 LAWS OF BRUNEI 2 CAP. 114 Poisons 18. Jurisdiction. 19. Prosecutions. 20. Prohibition of sale to persons under 18. 21. Rules. SCHEDULE — POISONS LIST ____________________________ LAWS OF BRUNEI Poisons CAP. 114 3 POISONS ACT An Act to regulate the importation, possession, manufacture, compounding, storage, transport and sale of poisons Commencement: 1st January 1983 [S 61/1957] Citation. 1. This Act may be cited as the Poisons Act. Interpretation. 2. In this Act, unless the context otherwise requires — “dentist” means a dentist licensed under the Medical Practitioners and Dentists Act (Chapter 112) and includes a Government dentist; “export”, in relation
    [Show full text]
  • Etats Rapides
    List of European Pharmacopoeia Reference Standards Effective from 2015/12/24 Order Reference Standard Batch n° Quantity Sale Information Monograph Leaflet Storage Price Code per vial Unit Y0001756 Exemestane for system suitability 1 10 mg 1 2766 Yes +5°C ± 3°C 79 ! Y0001561 Abacavir sulfate 1 20 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0001552 Abacavir for peak identification 1 10 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0001551 Abacavir for system suitability 1 10 mg 1 2589 Yes +5°C ± 3°C 79 ! Y0000055 Acamprosate calcium - reference spectrum 1 n/a 1 1585 79 ! Y0000116 Acamprosate impurity A 1 50 mg 1 3-aminopropane-1-sulphonic acid 1585 Yes +5°C ± 3°C 79 ! Y0000500 Acarbose 3 100 mg 1 See leaflet ; Batch 2 is valid until 31 August 2015 2089 Yes +5°C ± 3°C 79 ! Y0000354 Acarbose for identification 1 10 mg 1 2089 Yes +5°C ± 3°C 79 ! Y0000427 Acarbose for peak identification 3 20 mg 1 Batch 2 is valid until 31 January 2015 2089 Yes +5°C ± 3°C 79 ! A0040000 Acebutolol hydrochloride 1 50 mg 1 0871 Yes +5°C ± 3°C 79 ! Y0000359 Acebutolol impurity B 2 10 mg 1 -[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino] propoxy]phenyl] 0871 Yes +5°C ± 3°C 79 ! acetamide (diacetolol) Y0000127 Acebutolol impurity C 1 20 mg 1 N-(3-acetyl-4-hydroxyphenyl)butanamide 0871 Yes +5°C ± 3°C 79 ! Y0000128 Acebutolol impurity I 2 0.004 mg 1 N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl] 0871 Yes +5°C ± 3°C 79 ! butanamide Y0000056 Aceclofenac - reference spectrum 1 n/a 1 1281 79 ! Y0000085 Aceclofenac impurity F 2 15 mg 1 benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate
    [Show full text]